Transcript Highlights:

• We're opposed to the expansion of DHSS and, in particular, we saw what happened with COVID.
• We're opposed to the expansion of DHSS and, in particular, we saw what happened with COVID.
• opt-in just to be part of that process, not to enforce orders, not to, you know, create this broad expansion
• opt-in just to be part of that process, not to enforce orders, not to, you know, create this broad expansion
• HB 2355 is not a permanent expansion of services.

Committee: House Health and Mental Health

Summary: The committee first met in executive session and voted House Bill 2309, Representative Jones’ Oregon Harvesting bill, do pass by a vote of 13 ayes and no nays. The committee then moved to public testimony on House Bill 1881, which would schedule xylazine as a controlled substance. Representative Bill Allen said the bill is intended to address xylazine’s role in fentanyl-related overdoses, improve tracking and enforcement, and preserve legitimate veterinary use through carve-outs. A veterinarian from the University of Missouri testified in support, emphasizing xylazine’s long-standing and safe veterinary use and the need to protect agricultural practice while targeting illicit diversion. No opposition was presented, and testimony on the bill concluded. The committee then heard House Bill 1855, which would add alpha-gal syndrome to Missouri’s reportable conditions and create a reporting/surveillance framework. Sponsor Representative Matthew Overcast said the bill was revised to shift reporting from providers to private labs, create a standalone non-communicable disease reporting section, and support data collection for prevalence, education, and federal funding opportunities. Supporters included a lobbyist for the AlphaGal Alliance, a University of Missouri dermatologist/researcher, Extension staff, cattle industry representatives, and multiple patients and family members who described severe dietary restrictions, anxiety, school and work impacts, and the need for better public awareness and treatment research. Opponents argued the bill’s language would expand DHSS authority too broadly, especially the provision allowing the department to designate and enforce rules for noncommunicable diseases, and suggested narrowing the bill and adding opt-in protections. No vote was taken. Finally, the committee began hearing House Bill 2355, Representative Holly Jones’ “food as medicine” bill. Jones argued that nutrition should be treated as a public health intervention and described medically tailored meals, produce prescriptions, and nutrition counseling as tools that can improve outcomes and reduce costs. In questions, members raised concerns about how the proposal would interact with existing food assistance programs such as SNAP, WIC, school meals, and other federal nutrition benefits, and whether the bill would create a new entitlement or duplicate existing aid. The hearing on HB 2355 was still in progress when the transcript ended.

Transcript Highlights:

• enhances the competitiveness of the BDO grant process and provides tax relief to support broadband expansion
• that other pharmaceuticals like Abilify and Lamictal also.
• Take your pick of any of the pharmaceuticals that you see on TV that are meant to help with psychotropics
• The TCUP expansion is the latest program designed to help.
• Or weekly as an alternative to pharmaceuticals.

Bills: SB31 , SB33 , SB20 , SB217 , SB264 , SB269 , SB650 , SB681 , SB528 , SB502 , SB740 , SB916 , SB995 , SB10 , SB2581 , SB2570 , SB3031 , SB24 , SB379 , SB1171 , SB1121 , SB1120 , SB1061 , SB1036 , SB1019 , SB890 , SB11 , SB868 , SB1188 , SB1254 , SB2778 , SB2543 , SB2443 , SB1333 , SB1259 , SB1401 , SB1404 , SB2139 , SB2165 , SB2237 , SB2268 , SB1202 , SB1198 , SB1212 , SB1451 , SB1470 , SB1498 , SB965 , SB1547 , SB1667 , SB1818 , SB1902 , SB2129 , SB2078 , SB2069 , SB1737 , SB1589 , SB1318 , SB387 , SB1150 , SB1574 , SB2127 , SB3034 , SB860 , SB1278 , SCR5 , SCR32 , SB4 , SB23 , SB1762 , SB34 , SB60 , SB706 , SB1814 , SB1220 , SB523 , SB565 , SB1253 , SB840 , SB764 , SB2383 , SB2155 , SB1535 , SB1423 , SB1566 , SB1804 , SB1728 , SB1816 , SB1952 , SB75 , SB2068 , SB1455 , SB213 , SB627 , SB2037 , SB670 , SB896 , SB917 , SB1184 , SB971 , SB1255 , SB1261 , SB1283 , SB991 , SB1733 , SB21 , SB231 , SB739 , SB1252 , SB1371 , SB646 , SB3 , SCR27 , SB552 , SB1405 , SB1948 , SB243 , SJR1 , SB31 , SB33 , SB20 , SB217 , SB264 , SB269 , SB650 , SB681 , SB528 , SB502 , SB740 , SB916 , SB995 , SB10 , SB2581 , SB2570 , SB3031 , SB24 , SB379 , SB1171 , SB1121 , SB1120 , SB1061 , SB1036 , SB1019 , SB890 , SB11 , SB868 , SB1188 , SB1254 , SB2778 , SB2543 , SB2443 , SB1333 , SB1259 , SB1401 , SB1404 , SB2139 , SB2165 , SB2237 , SB2268 , SB1202 , SB1198 , SB1212 , SB1451 , SB1470 , SB1498 , SB965 , SB1547 , SB1667 , SB1818 , SB1902 , SB2129 , SB2078 , SB2069 , SB1737 , SB1589 , SB1318 , SB387 , SB1150 , SB1574 , SB2127 , SB3034 , SB860 , SB1278 , SCR5 , SCR32 , SB546 , SB647 , SB648 , SB1493 , SB1709 , SB2001 , HB5669 , HB3115 , HB5655 , HB5675 , HB5689 , HB5690 , HB5653 , HB3228 , HB2802 , HB45 , HB1318 , HB5560 , HB2894 , HB4344 , HB2775 , HB33 , HB 12 , HB148

Keywords: SB 31, Life of the Mother Act, Texas abortion law, medical emergency, reasonable medical judgment, pregnancy complications, maternal health, life-threatening condition, ectopic pregnancy, spontaneous abortion, miscarriage, unborn child, abortion exception, abortion ban, physician liability, health care liability claim, aiding and abetting, Texas Medical Board, State Bar of Texas, continuing medical education

Transcript Highlights:

• You know, so for a pharmaceutical, for a potential therapeutic, let's say.
• Pharmaceutical companies are not looking at CPRIT as being the biggest investor with the biggest return
• But with a lot of pharmaceutical companies, that is not the magic moneymaker.
• And, again, not being greedy, but I think that when we look at the margins. of pharmaceutical drugs or
• Any other pharmaceutical substance is prescribed based on weight, size, and other individual factors.

Bills: SB623 , SB1266 , SB1310 , SB1373 , SB1580 , SB1952 , SB2032 , SB2269 , SB2544 , SB2653 , SB2796

Committee: Senate Health & Human Services

Keywords: pharmacist, vaccine administration, COVID-19, exclusive authority, healthcare, Medicaid, provider enrollment, credentialing, administrative burden, Texas Health and Human Services, senior retirement communities, emergency response, residential safety, contract provisions, health and safety regulations, medical staff privileges, hospital administration, healthcare regulation, Texas Health and Safety Code, consistency in privileges

Transcript Highlights:

• its place we are adding the provisions of Senate Bill 14, which prohibits discrimination by a pharmaceutical
• 02:51.480><c> a</c> prohibits the Discrimination uh by a prohibits the Discrimination uh by a pharmaceutical
• that it was established but it um 90s that it was established but it um allows<00:05:47.080><c> pharmaceutical
• </c><00:05:47.800><c> manufacturers</c><00:05:48.759><c> to</c> allows pharmaceutical manufacturers to
• allows pharmaceutical manufacturers to sell<00:05:50.240><c> products</c><00:05:50.680><c> sell</c><

Keywords: 00:25 Call to Order/Roll Call 01:36 Discussion of 25RS SB 153 23:11 Roll Call Vote on 25RS SB 153 30:56 Adjournment, 958, all

Summary: The House Standing Committee on Health Services met on March 14, 2025, and took up a committee substitute for Senate Bill 153. The substitute deleted the original bill language and replaced it with provisions from Senate Bill 14, aimed at prohibiting pharmaceutical manufacturers from discriminating against 340B covered entities and adding reporting requirements for those entities. The sponsor explained that the protections would sunset after one year, allowing lawmakers to review data by July 1, 2026, and that Kentucky would continue to follow any future federal changes to the 340B program. Members asked several questions about the scope of the reporting, including what “total operating cost” means, how duplicate discounts are prevented, whether the reporting applies only to hospitals and not federally qualified health centers, and who would receive the data. The sponsor said the reporting is intended to help the Cabinet for Health and Family Services and the Office of Health Data Analytics at LRC assess how the program is working, including charity care and community benefits, while preserving protections for rural hospitals and allowing them to continue using contract pharmacies. A representative from LRC confirmed the data would come to the General Assembly through the Office of Health Data Analytics. The committee expressed mixed views about the balance between transparency and potential burdens on hospitals, especially rural facilities. Several members said they were supportive but had reservations about the reporting requirements and the sunset structure, while others noted concerns about unintended consequences and the possibility of changes on the House floor. The committee ultimately adopted the committee substitute, approved a title amendment, and reported Senate Bill 153 with House Committee Substitute 2 favorably. The meeting then adjourned.

Transcript Highlights:

• For some patients, becoming healthier reduces the need for pharmaceutical prescriptions.
• </c> prescribe most pharmaceutical prescribe most pharmaceutical medications<01:37:27.280><c> other</
• </c> reduces the need for pharmaceutical reduces the need for pharmaceutical prescriptions.<01:37:34.680
• Like, we prescribe pharmaceuticals when we need to, if we need to.
• /c><01:45:34.320><c> need</c> prescribe pharmaceuticals when we need prescribe pharmaceuticals when we

Committee: House Commerce and Consumer Affairs

Keywords: 1189, house, all

Transcript Highlights:

• universities, cutting-edge research institutions, skilled workers, and a growing base of biotechnology, pharmaceutical
• Cutting-edge research institutions, skilled workers, and a growing base of biotechnology, pharmaceutical
• Under current law, a pharmaceutical or medical device manufacturer must first complete the lengthy federal
• Under current law, a pharmaceutical manufacturer must complete the full federal FDA approval process

Summary: The Senate convened with prayer and the Pledge of Allegiance, received committee reports, and approved the prior day’s journal by a 50-0 vote. Several members were granted leaves of absence, and the chamber also took up a number of procedural motions, including re-referring Senate Bill 1212 to Appropriations and moving Senate Bill 911 from the table to the calendar. The Senate later recessed for committee meetings and party caucuses, then reconvened to continue floor action. On the calendar, Senate Bill 1206 passed 50-0 after supporters said it would help Pennsylvania’s life sciences industry by allowing manufacturers to pursue state licensure while federal FDA approval is pending, without weakening safety standards. Senate Bill 1273 passed 48-2; its sponsor said it would clarify that turnpike automated plate-reading data may be shared with investigators in missing or endangered persons cases, including Amber Alerts. Several other bills were either agreed to and re-referred to Appropriations or ordered over in their place, including House Bill 681, Senate Bills 1061, 1303, and 1355, and House Bill 1505 and 1667. The Senate also considered Senate Resolution 326, where an amendment by Senator Mastriano was adopted and the resolution was then held over as amended. In executive session, the chamber returned several nominations to the governor, then confirmed a slate of gubernatorial nominations, including appointments to the Pennsylvania Drug, Device, and Cosmetic Board, the State Board of Osteopathic Medicine, and several Pennsylvania Army National Guard promotions, by a 50-0 vote. The Senate additionally approved committee-reported bills from Appropriations and Health and Human Services, and signed House Bill 1344 in the presence of the Senate. During petitions and remonstrances, Senator Tartaglione urged action on minimum wage legislation, noting Pennsylvania has not raised the wage since 2006 and pointing to House Bill 2189. Senator Dush delivered extended remarks on the nation’s founding and the religious views of Benjamin Franklin. The Senate then adopted a motion to recess until June 25, 2026, at 9:30 a.m., unless recalled sooner.

Transcript Highlights:

• Waste, fraud, and abuse thrive where welfare benefits are expansive and oversight is weak.
• Medicaid's expansion into non-medical services increased these risks.
• This creates perverse incentives that weaken program integrity and encourage welfare expansion.
• Expansion in other states has been characterized by low-value spending and increased improper payments
• To address these issues, Texas should continue to resist further expansion of Medicaid, particularly

Committee: Senate Health & Human Services

Keywords: 1185, senate, all

Transcript Highlights:

• </c> discretion of a pharmaceutical company. discretion of a pharmaceutical company.
• </c><02:07:39.679><c> of</c> um, House Bill 115 FN is an expansion of um, House Bill 115 FN is an expansion
• Republicans, Democrats, independents alike, do not support the expansion of EFAs.
• Got places like to voucher expansion.
• </c> opposing the voucher expansion program. opposing the voucher expansion program.

Committee: Senate Education

Keywords: 1191, senate, all

Transcript Highlights:

• When I look at rising health care costs, it's often due to rising pharmaceutical costs, the rising cost
• It would depend on how expansive in scope those are and how expensive those are, and that would determine
• Pharmaceutical costs keep going up, provider costs keep going up, you know, just inflation is now hitting
• Pharmaceutical costs keep going up, provider costs keep going up, you know, just inflation is now hitting
• Pharmaceutical costs keep going up, provider costs keep going up, you know, just inflation is now hitting

Bills: HF747 , HF1014 , HF320 , HF400

Committee: House Commerce Finance and Policy

Keywords: corporate governance, shareholder rights, beneficial ownership, defective corporate acts, Minnesota Business Corporation Act, Minnesota Insurance Guaranty Association, MIGA, insurance guaranty fund, insurer insolvency, covered claim, net worth threshold, high-net-worth insured, financial information request, insurance claims, self-insured retention, deductible, commercial insurance, insurance regulation, Minnesota Statutes 60C.09, guaranty association

Transcript Highlights:

• Vaccines, just like many other pharmaceutical products, are not one-size-fits-all.
• My career has been dedicated to diagnostics and pharmaceuticals.
• You have been hijacked by the big pharmaceutical companies.
• You worship pharmaceuticals like religion. It is insane. It is absolutely insane.
• Pharmaceutical companies, you have all become indoctrinated. It is shameful.

Committee: Joint Joint Committee on Public Health

Keywords: 995, all

Summary: The Joint Committee on Public Health held a hearing on several vaccination-related bills, including proposals to eliminate non-medical or religious exemptions for school immunizations (notably H. 2554 and S. 1557), a bill to require or improve reporting and administration of immunization data and exemptions (described as the Community Immunity Act, S. 1618), and H. 2431, which would prohibit COVID-19, mRNA, or gene-altering vaccine requirements. The committee also heard testimony on H. 2463, which would classify funeral directors as public health workers for vaccine-priority purposes during emergencies. The chair reviewed testimony rules and repeatedly asked speakers to keep comments orderly and brief so the committee could hear as many people as possible. No votes were taken during the hearing. Testimony on H. 2554 and S. 1557 was sharply divided. Pediatricians, infectious disease specialists, public health advocates, and groups such as the Massachusetts Chapter of the American Academy of Pediatrics, Massachusetts Medical Society, March of Dimes, Massachusetts Families for Vaccines, and several parents supported eliminating religious exemptions, arguing that vaccination protects medically vulnerable children and adults, improves herd immunity, and helps prevent outbreaks of measles, pertussis, and other diseases. They cited local school data showing pockets of lower coverage and incomplete reporting, and several speakers referenced outbreaks in other states and the need for stronger, more consistent reporting and exemption management. Opponents argued the bills would infringe on religious freedom and parental rights, force families to choose between faith and education, and unfairly target a small number of families; some also said Massachusetts already has high vaccination rates and that the real issue is incomplete data or the gap population rather than religious exemptions. H. 2431 drew testimony from supporters who said COVID-era mandates caused job losses, privacy concerns, and harm, and that the bill would prevent future requirements for COVID, mRNA, or gene-altering vaccines in schools, workplaces, and public settings. Supporters described personal experiences with alleged vaccine injury or mandate-related hardship. H. 2463 was supported by the Massachusetts Funeral Directors Association, which argued funeral directors work in infection-facing settings and should be eligible for vaccine priority during public health emergencies. The hearing featured extensive public testimony but no committee action beyond hearing the bills and taking questions from members.

Transcript Highlights:

• I was formerly chief marketing officer for a global pharmaceutical company where I was beaten nearly
• I worked for the subsidiary Stratford Pharmaceuticals. I lost my livelihood.
• I was formerly chief marketing officer for a global pharmaceutical company where I was beat nearly to
• I worked for the subsidiary Stratford Pharmaceuticals. I lost my livelihood. I agree.
• I worked for the subsidiary Stratford Pharmaceuticals. I lost my livelihood.

Bills: S0212 , S0656 , S0682 , S0810 , S0812 , S0890 , S0892 , S0900 , S0928 , S1084 , S1284

Committee: Senate Criminal Justice

Keywords: sexual offender, sexual predator, sex offender registry, child protection, residency restriction, loitering, proximity restriction, public swimming pool, school safety, child care facility, day care center, park, playground, conditional release, probation, community control, warrantless arrest, background check, registry screening, minor victims

Summary: The committee took up a series of criminal justice and public safety bills. SB 1084, which exempts certain identifying and location information for non-legal support staff in state attorneys’ offices from public records requests, was supported by prosecuting attorneys and reported favorably. SB 212, as amended, created new restrictions related to sexual offenders and predators, including a 200-foot restricted presence provision near certain locations and updated notification/supervision requirements; it drew strong opposition from researchers, advocates, and affected families who argued it lacked evidence and would increase homelessness, but it was reported favorably. SB 682, addressing domestic violence, coercive control, strangulation, animal abuse, injunctions, and related training and enforcement issues, received emotional survivor testimony and support from animal welfare and law enforcement groups and was reported favorably. SB 656, creating and renaming FDLE Internet Crimes Against Children funding and grant programs, was amended and reported favorably and unanimously. The committee also considered SB 810 on sealing criminal history records, which would expand eligibility for some non-conviction records and one low-level misdemeanor conviction after waiting periods and judicial review; supporters said Florida is unusually restrictive, while one senator raised concerns about the scope, and the bill was reported favorably. SB 890, creating a standalone battery by strangulation offense applicable outside domestic relationships, was reported favorably after the sponsor said it would close a gap in current law. SB 892, revising habitual offender and violent career criminal sentencing procedures and notice requirements, was reported favorably, with defense lawyers supporting the clearer pretrial notice. SB 928, “Missy’s Law,” requiring immediate remand to custody after conviction of certain dangerous crimes, was amended to include computer pornography/child exploitation offenses and reported favorably after a family member of the namesake victim testified in support. Later, SB 1284 modernized arrest and search warrant statutes, expanding judicial summons options for some misdemeanors and broadening warrant/arrest authority in certain DUI, injunction, domestic violence, and misdemeanor force cases; defense lawyers supported the judicial-discretion portions but raised concerns about DUI/BUI arrests, and the bill was reported favorably. Finally, SB 812, a technical companion to SB 810 updating public records treatment for sealed criminal history records, was amended to clarify prosecutorial access for later cases and reported favorably. Several bills were supported by law enforcement, prosecutors, and advocacy groups, while others drew opposition from civil liberties, treatment, homelessness, and criminal defense advocates. The meeting adjourned after members recorded additional votes on selected tabs.

Transcript Highlights:

• The expansion of the OSU Medical Center will include pharmaceutical research laboratories, new ORs, and
• So that's why you see a work requirements for Medicaid expansion line down here.
• I want to shift over to Medicaid expansion. It's a big deal, and that's some of the...
• Do you know where we're at right now on Medicaid expansion?
• And this expansion group is high utilization.

Summary: The subcommittee heard budget presentations and questions from several health and human services agencies, with members repeatedly emphasizing that agency numbers had been posted since October and that questioning should stay focused and brief. The Office of Juvenile Affairs said its $5.45 million request would support 162 employees receiving a pay adjustment, and members asked about juvenile care conditions and staffing. The Department of Human Services discussed major changes to child care subsidy funding, including a reduced subsidy request, a $11.5 million child care teacher recruitment/retention request, and planned eligibility and reimbursement changes; it also reviewed SNAP administrative cost shifts under federal law, the state’s SNAP error rate, and the risk of large future state costs if the error rate is not reduced. DHS also addressed TANF reserves, the DDS waiver wait list, the Greer Center buildout, the Advantage waiver supplemental, and meal service options for waiver members. OCCY described a largely personnel-driven budget, requests for more oversight staff, and workload pressures in juvenile competency evaluations. The Office of Disability Concerns reported a flat budget and said it relies mainly on mediation and informal resolution rather than enforcement. OSU Medical Authority said its Tulsa expansion, VA skybridge, and c-section suites remain on schedule, that psychiatric residency funding is being phased in over several years, and that it is working to reduce contract labor and evaluate service lines. J.D. McCarty Center reported its new ABA outpatient clinic is on time and on budget and is nearing full capacity. OMMA said its lab is following required standards, its FTE count is below budgeted levels because hiring depends on lab accreditation and other unknowns, and dispensary numbers continue to decline as the market matures. Oklahoma Rehabilitation Services said it needs about $1.4 million to avoid a maintenance-of-effort penalty and discussed aging campus capital needs and staffing vacancies. The Oklahoma Health Care Authority then outlined a very large budget requirement driven by utilization growth and the shift to value-based care, saying FY26 is currently stable but FY27 would likely require additional appropriations if the request is not fully funded.

Transcript Highlights:

• of the committee, for the record, my name is Jeremy Browning, and I represent Otsuka America Pharmaceutical
• There are rebates that the pharmaceutical companies give for medications and negotiations with Access
• When we've raised that issue with the pharmaceutical companies in the past, they kind of laughed at us
• When we've raised that issue with the pharmaceutical companies in the past, they kind of laughed at us
• Great, so we could count on the pharmaceutical companies dropping the price of their medications.

Summary: The committee first heard Senate Bill 1630, which would direct AHCCCS to seek federal approval for a home- and community-based services program for adults determined to be seriously mentally ill, with quarterly implementation updates, a stakeholder work group, and a cap on enrollment. The sponsor and advocates from Arizona Mad Moms argued the bill would create a Medicaid-funded long-term care option for the most disabled SMI patients, reduce costly hospital and state-only care, and improve continuity of care. A committee amendment narrowed eligibility to individuals needing a long-term SMI level of care, changed reporting to semiannual, reduced the initial cap to 250 members with possible growth tied to savings, and required AHCCCS to keep pursuing approval if CMS denies it. The amendment was adopted, and SB 1630 as amended passed 10-0. The committee then considered Senate Bill 1131, which originally required every school district and charter school to adopt a cardiac emergency response plan and appropriated $1 million for implementation. A Warner amendment replaced the mandate with a reporting requirement on AED counts, CPR/AED-trained staff, and whether a plan exists, while shifting the appropriation toward AED grants and limiting school spending to purchasing and maintaining AEDs. The American Heart Association supported the amendment as a way to gather baseline data and target resources, while some members questioned the funding split and the rural-school priority. The amendment was adopted, and SB 1131 as amended passed 9-1. Next, the committee took up Senate Bill 1582, dealing with the school safety interoperability fund. The amendment changed the appropriation from ADE to ADOA and allocated funds to specific county sheriff’s offices to continue existing interoperable communication systems linking schools and first responders; supporters said the systems had been used in drills and some real incidents, and were important for school safety. One member raised concerns about the auditor general’s report and whether the program should continue, but sheriffs and school officials described it as a useful communication tool. The amendment was adopted, and SB 1582 as amended passed 6-4. Finally, the committee began hearing Senate Bill 1504, which would change retirement rules for Tier 2 and Tier 3 public safety personnel and reduce the waiting period for cost-of-living adjustments. The sponsor, police and fire representatives, and pension consultants argued the bill would improve recruitment and retention and align benefits more closely with what employees were promised, while cities, counties, and taxpayer groups warned it would add substantial unfunded liabilities and undermine the 2016 pension reforms. The committee spent extensive time on actuarial costs, funding status, and the effect of the amendment exempting the bill from statutory pre-funding requirements; the transcript ends during that discussion before a final vote on SB 1504 is shown.

Transcript Highlights:

• approval process and the secrecy about vaccines from prescriptions, whatever they are, any of the pharmaceutical
• approval process and the secrecy about vaccines from prescriptions, whatever they are, any of the pharmaceutical
• approval process and the secrecy about vaccines from prescriptions, whatever they are, any of the pharmaceutical
• approval process and the secrecy about vaccines from prescriptions, whatever they are, any of the pharmaceutical
• approval process and the secrecy about vaccines from prescriptions, whatever they are, any of the pharmaceutical

Committee: Senate State and Local Government

Keywords: 1187, senate, all

Transcript Highlights:

• Lieder and Suckla, also Senators Kipp and Rich, concerning the continuation of the Veterinary Pharmaceutical
• and Rich concerning the continuation of the<01:18:12.239><c> Veterinary</c><01:18:12.640><c> Pharmaceutical
• </c><01:18:13.199><c> Advisory</c> the Veterinary Pharmaceutical Advisory the Veterinary Pharmaceutical
• Agencies to repeal<01:18:19.280><c> the</c><01:18:19.440><c> Veterinary</c><01:18:19.840><c> Pharmaceutical
• </c> repeal the Veterinary Pharmaceutical repeal the Veterinary Pharmaceutical Advisory<01:18:20.880>

Keywords: 981, all

Transcript Highlights:

• PBMs were originally created to negotiate drug prices with pharmaceutical manufacturers.
• PBMs were originally created to negotiate drug prices with pharmaceutical manufacturers.
• Do you believe that pharmaceutical manufacturers are going to maintain the status quo?
• How do you feel about how pharmaceutical manufacturers would treat that in the event that negotiation

Bills: SB511 , SB512 , HB591 , HB909 , HB938 , HB1154 , HB1187

Committee: Senate Insurance

Keywords: automobile repairs, insurance transparency, repair shop liability, non-OEM parts, policyholder rights, automobile insurance, appraisal process, insurance policyholders, dispute resolution, claim valuation, family leave, insurance, paid leave, employment benefits, caregiver support, behavioral health, crisis services, mental health care, insurance coverage, healthcare access

Transcript Highlights:

• They are legally defined as emergency tools and not regulated pharmaceuticals.
• They are legally defined as emergency tools and not regulated pharmaceuticals.
• products should be made without any government influence or oversight, not to mention that all pharmaceuticals
• Medical journals have maintained a corporate kleptocratic relationship with the pharmaceutical industry

Summary: The Senate Health and Welfare Committee approved the February 10, 2026 minutes and then took up Senate Bill 1346, a measure proposing a two-year pause on mRNA-based COVID-19 products for pregnant women and children. Senator Shippey presented the bill as a targeted safety pause to allow more long-term review, saying it was not a blanket ban and that amendments were likely needed to clarify the bill’s language and the process for reviewing safety data. He also said the committee should send the bill to the 14th order for possible amendments. The committee heard extensive testimony both for and against the bill. Supporters, including Nicholas Holster, Christina Parks, James Thorpe, Laura Dembray, Xavier Figueroa, and several others, argued that mRNA products are unsafe, described them as gene therapy, and cited alleged harms to fertility, pregnancy, children, and broader health outcomes. Opponents, including physician Stephen Montemot, Primo Castro of the Biotechnology Innovation Organization, and parent Stephanie Neymour, argued that mRNA vaccines are not gene therapy, that the bill would restrict parental choice and access to medical care, and that decisions should remain with patients and doctors. Committee members also questioned the bill’s definitions, the legislature’s ability to review scientific data, the scope of the exemption for cancer and genetic disorder therapies, and whether the measure would affect other vaccines. After debate, members expressed mixed views: some supported further work on the bill, while others raised concerns about government overreach, the breadth of the definitions, and whether the legislature had the expertise or mechanism to evaluate safety data. Senator Lenny moved to send SB 1346 to the 14th order for possible amendments, and the motion passed by roll call vote, 5-4. The committee then adjourned.

Transcript Highlights:

• With that said, I'm not aware of any pharmaceutical that we allow people to produce at home because of
• However, it also represents a clear expansion of the medical marijuana program that has serious issues
• </c><01:28:05.440><c> of</c><01:28:05.560><c> the</c> represents a clear expansion of the represents
• Is the expansion still part of that organization, and is it one board of directors?
• Is the expansion still part of that organization, and is it one board of directors?

Committee: House Health, Human Services & Elderly Affairs

Keywords: 1189, house, all

Transcript Highlights:

• It's a huge benefit to the pharmaceutical industry.
• And those pharmaceutical companies can then scale It translates discoveries into products, and those
• Right now, the U.S. has the privilege of leading the world in scientific advancement for pharmaceutical
• I think that we should lean into it and figure out ways to support not just the pharmaceutical industry
• As you've probably read, there's a lot of pharmaceutical companies that have advertised that they're

Summary: The Assembly Select Committee on Biotechnology and Medical Technology met on August 19, 2025 to examine the effects of federal grant cuts, tariff uncertainty, and related policy changes on California’s biotech, medtech, and academic research ecosystem. The chair and panelists emphasized California’s outsized role in the industry, describing major clusters in the Bay Area, Los Angeles, and San Diego, and explaining how research, startup formation, manufacturing, and clinical trials are interconnected across the state. Speakers from Biocom California, California Life Sciences, Farma, UC, Stanford, CSU Biotech, and UCLA all argued that NIH and NSF funding are foundational to discovery, workforce training, and commercialization, and that disruptions are already chilling venture capital, startup formation, and hiring. Witnesses described several concrete impacts: suspended or terminated grants, reduced doctoral admissions, fewer training opportunities, canceled retreats and internships, and anxiety among graduate students and early-career researchers. UC reported hundreds of millions of dollars in suspended or terminated NIH and NSF funding, while Stanford said more than a thousand training and career-development grants nationwide have been frozen or ended, affecting multiple trainees per grant. CSU Biotech said 133 federal grants had been terminated, scaled back, or canceled, totaling about $140 million, including nearly $30 million from NIH and NSF. Industry representatives also warned that proposed antitrust limits on mergers and acquisitions could undermine the standard biotech exit path and further deter investment. Committee members asked about the duration of the disruption, the possibility of state action to offset federal losses, and whether California could better support workforce development, manufacturing, and R&D tax credits. Panelists urged the Legislature to preserve and expand state support for STEM education, internships, apprenticeship pathways, manufacturing incentives, and the R&D tax credit, and to consider infrastructure and housing as part of competitiveness. They also noted that tariffs are already raising costs for medtech components and building materials, and that China is increasingly competing for R&D, talent, and licensing deals. No formal votes or bill actions were taken at the hearing; the meeting was informational and focused on testimony and discussion.

Transcript Highlights:

• Texans deserve medical freedom to choose a safer alternative instead of harmful pharmaceuticals that
• faith, family, and freedom, and we have long held the position at our organization to oppose any expansion

Bills: HB46 , HB272

Committee: Senate State Affairs

Keywords: local government spending cap, expenditure limit, political subdivision, property tax, ad valorem tax, budget cap, taxpayer protection, spending restraint, inflation adjustment, population growth, voter approval, supermajority vote, county budget, municipal budget, school district finance, junior college district, hospital district, special district, attorney general enforcement, local fiscal limits

Summary: The Senate Committee on State Affairs heard several House bills and took no final votes, leaving each bill pending after testimony. HB 272 would align venue and evidentiary rules for fraudulent use or possession of credit/debit card information with existing credit card abuse law; the sponsor said it would improve prosecutions, and the Texas Financial Crimes Intelligence Center supported it. HB 1661 would increase penalties for certain election-related offenses, including failure to distribute election supplies and early release of election results; no substantive opposition was heard. HB 551 would protect the residential addresses of people who receive campaign expenditures on public Texas Ethics Commission reports, similar to donor privacy protections, and a witness from Texas Eagle Forum later indicated support for the privacy change. The committee also heard HB 2820, which would raise the amount charitable bingo organizations may keep in operating capital from $50,000 to $100,000. The sponsor and a Texans for Charitable Bingo representative said inflation and operating costs have made the current cap too low and that the bill would help charities maintain stable operations without expanding gaming. HB 3181 would impose stronger consequences for repeated denial of court-ordered child possession and access, including limiting probation and requiring attorney’s fees after multiple contempt findings; a family court judge and a parent testified in support, while another witness argued the bill should be paired with stronger criminal enforcement and that parents already face high costs. HB 4157 would update Texas law for commercial spaceflight by recognizing liability waivers and preserving workers’ compensation rights; no one testified against it. The committee also heard HB 4145, which would let health care providers satisfy a timely billing requirement by sending bills to a patient’s legal representative in a personal injury case, closing what supporters described as a loophole in letter-of-protection situations. Finally, HB 46, relating to the Texas Compassionate Use Program, drew the most extensive discussion: supporters said it should expand access for legitimate medical cannabis patients and add more delivery methods and conditions, while opponents warned against broader marijuana expansion and questioned adding chronic pain and other conditions. The sponsor said he still supports the program and wants a balanced, regulated expansion, but noted the bill is still being worked on. All bills were left pending at the close of the hearing.